National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer

NCI Features: Clinical Trials and You

    Posted: 06/01/2009

Making Progress Against Cancer

National Cancer Survivors Day is June 7, 2009. There are more than 12 million U.S. cancer survivors, thanks in large part to clinical trials. Clinical trials test new ways to prevent, detect, and treat disease in people. The National Cancer Institute (NCI) is a leading funder of cancer clinical trials.

On this page

Ask Your Doctor About Clinical Trials


Ask Your Doctor About Clinical Trials

Explore Resources for Health Care Professionals


Explore Resources for Health Care Professionals

Learn about NCI's Investment in Clinical Trials


Learn about NCI's Investment in Clinical Trials
  • The newly established Clinical Trials Reporting Program 12 will create a comprehensive database of NCI-supported clinical trials and will help NCI better manage its clinical trials portfolio.
  • NCI is restructuring its clinical trials enterprise 13 to speed the pace of bringing new treatments and prevention strategies to cancer patients. Greater coordination, careful priority setting, standard operations, and a robust informatics infrastructure are key elements in this new clinical trials enterprise.
  • Important clinical trials are in progress and have the potential to transform cancer therapy. Two examples:
  • The NCI Community Cancer Centers Program (NCCCP 17) is a pilot project that makes NCI clinical trials available in local communities.
  • See a video 18 about how researchers at the Lombardi Comprehensive Cancer Center in Washington, D.C., are sharing clinical trials data in real time using NCI's caBIG 19®  (cancer Biomedial Informatics Grid).
Learn More
  • Questions about clinical trials? NCI offers a variety of help options 20. To talk to someone in English or Spanish call 1-800-4-CANCER (1-800-422-6237); TTY: 1-800-332-8615.

Back to TopBack to Top



Table of Links

1http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/cancertop
ics/factsheet/Information/clinical-trials&fromUrl=/features/clinicaltrials2009
2http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/clinicalt
rials/learning/questions-to-ask-about-participating&fromUrl=/features/clinicalt
rials2009
3http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/clinicalt
rials/search&fromUrl=/features/clinicaltrials2009
4http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/clinicalt
rials/ctlaws-home&fromUrl=/features/clinicaltrials2009
5http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/clinicalt
rials&fromUrl=/features/clinicaltrials2009
6http://www.cancer.gov/clicklog.ashx?redirectUrl=http://cme.cancer.gov/clinicalt
rials/learning/course7.asp&fromUrl=/features/clinicaltrials2009
7http://www.cancer.gov/clicklog.ashx?redirectUrl=http://ctep.cancer.gov/&fromUrl
=/features/clinicaltrials2009
8http://www.cancer.gov/clicklog.ashx?redirectUrl=http://ctep.cancer.gov/investig
atorResources/investigators_handbook.htm&fromUrl=/features/clinicaltrials2009
9http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/ncicancer
bulletin/042109/page6&fromUrl=/features/clinicaltrials2009
10http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/clinicalt
rials/ctawareness&fromUrl=/features/clinicaltrials2009
11http://www.cancer.gov/clicklog.ashx?redirectUrl=https://cissecure.nci.nih.gov/n
cipubs/&fromUrl=/features/clinicaltrials2009
12http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/ncicancer
bulletin/021009/page9&fromUrl=/features/clinicaltrials2009
13http://www.cancer.gov/clicklog.ashx?redirectUrl=http://restructuringtrials.canc
er.gov&fromUrl=/features/clinicaltrials2009
14http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/clinicalt
rials/digestpage/TAILORx&fromUrl=/features/clinicaltrials2009
15http://www.cancer.gov/clicklog.ashx?redirectUrl=http://ccr.cancer.gov/&fromUrl=
/features/clinicaltrials2009
16http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/newscente
r/pressreleases/PhaseZeroAbbott
17http://www.cancer.gov/clicklog.ashx?redirectUrl=http://ncccp.cancer.gov/index.h
tm&fromUrl=/features/clinicaltrials2009
18http://www.cancer.gov/clicklog.ashx?redirectUrl=http://cabig.cancer.gov/action/
casestudies/Georgetown/&fromUrl=/features/clinicaltrials2009
19http://www.cancer.gov/clicklog.ashx?redirectUrl=http://cabig.cancer.gov/caBIGst
ory/vision/&fromUrl=/features/clinicaltrials2009
20http://www.cancer.gov/clicklog.ashx?redirectUrl=http://www.cancer.gov/help&from
Url=/features/clinicaltrials2009